Head & Neck Cancer

A team approach to treatment could improve outcomes for patients with head and neck cancer.

Being covered in cat fur feels wonderful.

The FDA granted Opdivo (nivolumab) a breakthrough therapy designation to treat certain patients with head and neck cancer.

A phase 3 study presented at the 2016 AACR Annual Meeting showed that Opdivo doubled one-year survival rate for patients with recurrent or metastatic head and neck squamous cell carcinoma.

A priority review designation was granted to Keytruda for some patients with head and neck cancer. A decision submission is due in August.

As the number of HNC survivors continues to increase, the American Cancer Society issued new guidelines for patients and their physicians.

Sometimes rational thinking isn't my strong suit.

For more than a year, the pain and restricted movement in my jaw are diagnosed as a common joint disorder, but a loss of hearing changes everything.

Like the song goes: "Some days are diamonds, some days are stones."

"This is what I've devoted my career to, and it is gratifying to see that really come to pass," says Robert Ferris.

The likelihood of developing oropharyngeal cancer was 22 times higher among individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples.

The study was stopped early after an independent monitoring panel determined the primary endpoint of improvement in OS was met.

Reflections on the wonders — and the hierarchy — of modern hospital care.

A poem about a two-year encounter with advanced cancer of the head and neck.

Recovery, like all good things, takes time. Don't short yourself.

Never underestimate the power and inner strength of a hungry cancer patient.

While the prognosis remains good for individuals with HPV-positive oropharyngeal cancers, researchers are currently seeking less intense treatment options that are equally effective but not as toxic.

Something in the way she moves ...

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses how patients with cancer can cope with body image issues.

Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses body images among patients and survivors of head and neck cancer.

Gypsyamber D'Souza and other researchers at the Johns Hopkins Bloomberg School of Public Health monitored 124 patients newly diagnosed with oropharyngeal cancer from 2009 through 2013.

Nausea and vomiting associated with anticancer therapies continue to be among patients' most troubling symptoms.

Removing lymph nodes in the neck before they are affected by oral squamous cell cancer is a life-saving measure and should be adopted as a new standard in treating the disease, according to the results of a phase 3 study.

The immunotherapy Keytruda (pembrolizumab), in a recent study, proved twice as effective for the treatment of head and neck cancer as Erbitux (cetuximab), the only targeted therapy indicated as a therapy for the disease.

Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the treatment of oral mucositis in patients with head and neck cancer.

Thanks to The Cancer Genome Atlas (TCGA) Research Network, researchers now have a better understanding of genomic alternations in head and neck cancers.

Cases of HPV-related cancers are on the rise, specifically those associated with head and neck and anal cancers.

In the right cancer, radiation and chemotherapy can make a powerful duo.